Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study-Reference-Cited by-全球学者库

Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study

Published:2016-04-28 Issue:5 Volume:31 Page:953-958
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

González Carlos A.¹,Sanz-Anquela José Miguel²,Companioni Osmel¹,Bonet Catalina¹,Berdasco María³,López Consuelo⁴,Mendoza Jorge⁵,Martín-Arranz Mª Dolores⁶,Rey Enrique⁷,Poves Elvira⁸,Espinosa Laura⁸,Barrio Jesús⁹,Torres Mª Ángeles¹⁰,Cuatrecasas Miriam¹¹,Elizalde Ignasi¹²,Bujanda Luis¹³,Garmendia Maddi¹³,Ferrández Ángel⁹,Muñoz Guillermo¹⁴,Andreu Victoria¹⁵,Paules Mª Jose¹⁶,Lario Sergio¹⁷,Ramírez Mª Jose¹⁷,Gisbert Javier P.⁵^ORCID,

Affiliation:

1. Unit of Nutrition, Environment and Cancer; Institut Català d'Oncología; Barcelona Spain

2. University of Alcalá (Department of Medicine and Medical Especialties), Department of Pathology; Hospital Universitario Príncipe de Asturias; Alcalá de Henares Spain

3. Cancer Epigenetics and Biology Program; IDIBELL; Barcelona

4. Department of Pathology; Hospital Universitario de la Princesa, IIS-IP, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Madrid

5. Department of Gastroenterology; Hospital Universitario de la Princesa, IIS-IP, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Madrid

6. Department of Gastroenterology; Hospital Universitario La Paz; Madrid

7. Department of Gastroenterology; Hospital Clínico San Carlos; Madrid Spain

8. Department of Gastroenterology; Hospital Universitario Príncipe de Asturias; Alcalá de Henares

9. Department of Gastroenterology; Hospital Universitario Río Hortega; Valladolid Spain

10. Department of Pathology; Hospital Universitario Río Hortega; Valladolid Spain

11. Department of Pathology, Hospital Clínic de Barcelona; IDIBAPS and CIBEREHD, and Universitat de Barcelona; Spain

12. Department of Gastroenterology; Hospital Clínic de Barcelona, IDIBAPS and CIBEREHD; Spain

13. Department of Pathology, and Department of Gastroenterology. Hospital Donostia/Instituto Biodonostia; Universidad del País Vasco (UPV/EHU). CIBEREHD; San Sebastián Spain

14. Department of Pathology; Hospital Clínico Universitario Lozano Blesa, Zaragoza, and CIBEREHD; Spain

15. Department of Gastroenterology; Hospital de Viladecans; Spain

16. Department of Pathology; Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat; Spain

17. Departament of Medicine, Digestive Diseases Service; Institut Universitari Parc Taulí, Sabadell, and CIBEREHD; Spain

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13249/fullpdf

Reference20 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010 (Dec 15)

2. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary;Sant;Ann. Oncol.,2003

3. Helicobacter pylori and gastric carcinogenesis;Correa;Am. J. Surg. Pathol.,1995

4. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study;Jass;Histopathology,1979

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions;JNCI: Journal of the National Cancer Institute;2024-01-23

2. Gastric intestinal metaplasia: progress and remaining challenges;Journal of Gastroenterology;2024-01-19

3. Gastric Cancer Risk Factors in a Veteran Population;Military Medicine;2023-08-23

4. Role of pre-existing incomplete intestinal metaplasia in gastric adenocarcinoma: A retrospective case series analysis;World Journal of Clinical Cases;2023-04-26

5. Cancer Progress and Priorities: Gastric Cancer;Cancer Epidemiology, Biomarkers & Prevention;2023-04-03